Furosemide Oral Solution shortage
Current 3 presentations · 1 manufacturers · first FDA posting Mar 31, 2026 · last update Oct 14, 2026
Manufacturers: Hikma Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Shortage of an inactive ingredient component
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Posted Mar 31, 2026 Updated Oct 14, 2026 | |
| Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Shortage of an inactive ingredient component | Available on allocation | Posted Mar 31, 2026 Updated Oct 14, 2026 |
| Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63) | Hikma Pharmaceuticals USA, Inc. | Current Available |
Shortage of an inactive ingredient component | Posted Mar 31, 2026 Updated Oct 14, 2026 |